{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:32:54Z","timestamp":1787239974513,"version":"build-2736575974"},"reference-count":39,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>PTH assays are not standardized; therefore, method-specific PTH reference intervals are required for interpretation of results. PTH increases with age in adults but age-related reference intervals for the Abbott intact PTH (iPTH) assay are not available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Deidentified serum PTH results from September 2015 to November 2022 were retrieved from the laboratory information system of a laboratory serving a cosmopolitan population in central-west England for individuals aged 18 years and older if the estimated glomerular filtration rate was \u226560\u2005mL\/min, serum 25-hydroxyvitamin D was &amp;gt;50\u2005nmol\/L, and serum albumin-adjusted calcium and serum phosphate were within reference intervals. Age-specific reference intervals for Abbott iPTH were derived by an indirect method using the refineR algorithm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PTH increased with age and correlated with age when controlled for 25-hydroxyvitamin D, estimated glomerular filtration rate, and adjusted calcium (r = 0.093, P &amp;lt; .001). The iPTH age-specific reference intervals for 4 age partitions of 18 to 45 years, 46 to 60 years, 61 to 80 years, and 81 to 95 years were 1.6 to 8.6\u2005pmol\/L, 1.8 to 9.5\u2005pmol\/L, 2.0 to 11.3\u2005pmol\/L, and 2.3 to 12.3\u2005pmol\/L, respectively. PTH was higher in women compared with men (P &amp;lt; .001). Sex-specific age-related reference intervals could not be derived because of the limited sample size.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Age-specific Abbott iPTH reference intervals were derived. Application of age-specific reference intervals will impact the diagnosis and management of normocalcemic hyperparathyroidism, based on current definitions, and secondary hyperparathyroidism. Additional studies are required to clarify the effect of sex and ethnicity on PTH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvae004","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T09:03:28Z","timestamp":1705050208000},"source":"Crossref","is-referenced-by-count":6,"title":["Age-specific Reference Intervals of Abbott Intact PTH\u2014Potential Impacts on Clinical Care"],"prefix":"10.1210","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1306-8832","authenticated-orcid":false,"given":"Tejas","family":"Kalaria","sequence":"first","affiliation":[{"name":"Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust , Birmingham, B15 2GW , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J","family":"Lawson","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust , Birmingham, B15 2GW , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Duffy","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust , Birmingham, B15 2GW , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashishkumar","family":"Agravatt","sequence":"additional","affiliation":[{"name":"Biochemistry, PDU Medical College , Rajkot, 360001 , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Harris","sequence":"additional","affiliation":[{"name":"Black Country Pathology Services, The Royal Wolverhampton NHS Trust , Wolverhampton, WV10 0QP , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Ford","sequence":"additional","affiliation":[{"name":"Black Country Pathology Services, The Royal Wolverhampton NHS Trust , Wolverhampton, WV10 0QP , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rousseau","family":"Gama","sequence":"additional","affiliation":[{"name":"Black Country Pathology Services, The Royal Wolverhampton NHS Trust , Wolverhampton, WV10 0QP , UK"},{"name":"School of Medicine and Clinical Practice, University of Wolverhampton , Wolverhampton, WV1 1LY , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Webster","sequence":"additional","affiliation":[{"name":"Clinical Biochemistry, University Hospitals Birmingham NHS Foundation Trust , Birmingham, B15 2GW , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarekegn","family":"Geberhiwot","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes, and Metabolism, Queen Elizabeth Hospital , Birmingham, B15 2TH , UK"},{"name":"Institute of Metabolism and Systems Research, University of Birmingham , Birmingham, B15 2TT , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"issue":"9684","key":"2024021906102862300_bvae004-B1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet (London, England)"},{"issue":"4","key":"2024021906102862300_bvae004-B2","doi-asserted-by":"crossref","first-page":"bvad013","DOI":"10.1210\/jendso\/bvad013","article-title":"The eucalcemic patient with elevated parathyroid hormone levels","volume":"7","author":"Shaker","year":"2023","journal-title":"J Endocr Soc"},{"issue":"11","key":"2024021906102862300_bvae004-B3","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"2024021906102862300_bvae004-B4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cca.2016.10.016","article-title":"Perspective and priorities for improvement of parathyroid hormone (PTH) measurement\u2014a view from the IFCC working group for PTH","volume":"467","author":"Sturgeon","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2024021906102862300_bvae004-B5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40618-016-0553-2","article-title":"How the reference values for serum parathyroid hormone concentration are (or should be) established?","volume":"40","author":"Souberbielle","year":"2017","journal-title":"J Endocrinol Invest"},{"issue":"7","key":"2024021906102862300_bvae004-B6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/a-1856-4900","article-title":"The diagnosis of normocalcaemic hyperparathyroidism is strikingly dissimilar using different commercial laboratory assays","volume":"54","author":"Kalaria","year":"2022","journal-title":"Horm Metab Res"},{"issue":"4","key":"2024021906102862300_bvae004-B7","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1210\/jc.2003-031539","article-title":"The effects of age and other variables on Serum parathyroid hormone in postmenopausal women attending an osteoporosis center","volume":"89","author":"Need","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2024021906102862300_bvae004-B8","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1210\/jc.2014-4370","article-title":"Brief report: does PTH increase with age, independent of 25-hydroxyvitamin D, phosphate, renal function, and ionized calcium?","volume":"100","author":"Carrivick","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024021906102862300_bvae004-B9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.arr.2012.06.001","article-title":"Age-related changes in the response of intestinal cells to 1(,25(OH)2-vitamin D3","volume":"12","author":"Gonzalez Pardo","year":"2013","journal-title":"Ageing Res Rev"},{"issue":"10","key":"2024021906102862300_bvae004-B10","doi-asserted-by":"crossref","first-page":"e10517","DOI":"10.1002\/jbm4.10517","article-title":"Renal contributions to age-related changes in mineral metabolism","volume":"5","author":"Irsik","year":"2021","journal-title":"JBMR Plus"},{"issue":"6","key":"2024021906102862300_bvae004-B11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/js.2017-00104","article-title":"Longitudinal assessment of PTH in community-dwelling older women-elevations are not associated with mortality","volume":"1","author":"Buchebner","year":"2017","journal-title":"J Endocr Soc"},{"issue":"2","key":"2024021906102862300_bvae004-B12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/cen.13486","article-title":"Parathyroid hormone: data mining for age-related reference intervals in adults","volume":"88","author":"Farrell","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024021906102862300_bvae004-B13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cca.2020.05.030","article-title":"Use of data mining in the establishment of age-adjusted reference intervals for parathyroid hormone","volume":"508","author":"Delgado","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"12","key":"2024021906102862300_bvae004-B14","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s40618-023-02107-2","article-title":"Big data-based parathyroid hormone (PTH) values emphasize need for age correction","volume":"46","author":"Cavalcante","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"2024021906102862300_bvae004-B15","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1373\/clinchem.2013.204222","article-title":"Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort","volume":"59","author":"Bailey","year":"2013","journal-title":"Clin Chem"},{"issue":"12","key":"2024021906102862300_bvae004-B16","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1515\/cclm-2019-0707","article-title":"Paediatric reference intervals for 17 Roche cobas 8000 e602 immunoassays in the CALIPER cohort of healthy children and adolescents","volume":"57","author":"Bohn","year":"2019","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"2024021906102862300_bvae004-B17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1515\/cclm-2017-0349","article-title":"Pediatric reference intervals for 29 Ortho VITROS 5600 immunoassays using the CALIPER cohort of healthy children and adolescents","volume":"56","author":"Higgins","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2024021906102862300_bvae004-B18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1515\/cclm-2015-0558","article-title":"Pediatric reference value distributions and covariate-stratified reference intervals for 29 endocrine and special chemistry biomarkers on the Beckman Coulter Immunoassay Systems: a CALIPER study of healthy community children","volume":"54","author":"Karbasy","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"2024021906102862300_bvae004-B19","volume-title":"Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory- Third Edition. CLSI Document EP28-A3c","author":"CLSI","year":"2008"},{"issue":"1","key":"2024021906102862300_bvae004-B20","doi-asserted-by":"crossref","first-page":"16023","DOI":"10.1038\/s41598-021-95301-2","article-title":"Refiner: a novel algorithm for reference interval estimation from real-world data","volume":"11","author":"Ammer","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"2024021906102862300_bvae004-B21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/clinchem\/hvac142","article-title":"RIbench: a proposed benchmark for the standardized evaluation of indirect methods for reference interval estimation","volume":"68","author":"Ammer","year":"2022","journal-title":"Clin Chem"},{"issue":"1","key":"2024021906102862300_bvae004-B22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1515\/cclm-2018-0073","article-title":"Indirect methods for reference interval determination\u2014review and recommendations","volume":"57","author":"Jones","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2024021906102862300_bvae004-B23","volume-title":"Hyperparathyroidism (Primary): Diagnosis, Assessment and Initial Management","author":"National Institute for Health and Care Excellence","year":"2019"},{"key":"2024021906102862300_bvae004-B24","volume-title":"NICE Clinical Knowledge Summaries: Vitamin D Deficiency in Adults","year":"2022"},{"issue":"2","key":"2024021906102862300_bvae004-B25","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EC-18-0432","article-title":"Vitamin D testing and treatment: a narrative review of current evidence","volume":"8","author":"Pilz","year":"2019","journal-title":"Endocr Connect"},{"key":"2024021906102862300_bvae004-B26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6890-8-12","article-title":"Derivation and internal validation of an equation for albumin-adjusted calcium","volume":"8","author":"James","year":"2008","journal-title":"BMC Clin Pathol"},{"key":"2024021906102862300_bvae004-B27","first-page":"149","article-title":"Twenty years of P-splines","volume":"39","author":"Eilers","year":"2015","journal-title":"SORT-Statistics Oper Res Trans"},{"issue":"3","key":"2024021906102862300_bvae004-B28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1467-9876.2005.00510.x","article-title":"Generalized additive models for location, scale and shape","volume":"54","author":"Rigby","year":"2005","journal-title":"J R Stat Soc Ser C (Applied Stat)"},{"issue":"1","key":"2024021906102862300_bvae004-B29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/jalm\/jfac101","article-title":"Estimation of reference intervals from routine data using the refineR algorithm-A practical guide","volume":"8","author":"Ammer","year":"2023","journal-title":"J Appl Lab Med"},{"issue":"2","key":"2024021906102862300_bvae004-B30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4158\/EP.12.2.137","article-title":"Reference range for serum parathyroid hormone","volume":"12","author":"Aloia","year":"2006","journal-title":"Endocr Pract"},{"issue":"3","key":"2024021906102862300_bvae004-B31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1530\/EJE-15-0595","article-title":"Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients","volume":"174","author":"Souberbielle","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2024021906102862300_bvae004-B32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2265.2010.03894.x","article-title":"Determinants of plasma PTH and their implication for defining a reference interval","volume":"74","author":"Rejnmark","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2024021906102862300_bvae004-B33","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00198-011-1776-x","article-title":"Demographic, dietary, and serum factors and parathyroid hormone in the National Health and Nutrition Examination Survey","volume":"23","author":"Paik","year":"2012","journal-title":"Osteoporos Int"},{"issue":"8","key":"2024021906102862300_bvae004-B34","doi-asserted-by":"crossref","first-page":"e10391","DOI":"10.1002\/jbm4.10391","article-title":"Normocalcemic hyperparathyroidism: a heterogeneous disorder often misdiagnosed?","volume":"4","author":"Zavatta","year":"2020","journal-title":"JBMR Plus"},{"issue":"1","key":"2024021906102862300_bvae004-B35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) guideline update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"2024021906102862300_bvae004-B36","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024021906102862300_bvae004-B37","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1210\/jc.2013-3349","article-title":"Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values","volume":"99","author":"Touvier","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2024021906102862300_bvae004-B38","doi-asserted-by":"crossref","first-page":"11224","DOI":"10.3389\/bjbs.2023.11224","article-title":"UK reference intervals for parathyroid hormone using Abbott methods","volume":"80","author":"Mirzazadeh","year":"2023","journal-title":"Br J Biomed Sci"},{"issue":"6","key":"2024021906102862300_bvae004-B39","doi-asserted-by":"crossref","first-page":"e23771","DOI":"10.1002\/jcla.23771","article-title":"Stability and validity of intact parathyroid hormone levels in different sample types and storage conditions","volume":"35","author":"Khalil","year":"2021","journal-title":"J Clin Lab Anal"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvae004\/55575183\/bvae004.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/3\/bvae004\/56676173\/bvae004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/3\/bvae004\/56676173\/bvae004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T01:10:48Z","timestamp":1708305048000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvae004\/7517789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,1,16]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvae004","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2024,1,12]]},"article-number":"bvae004"}}